Trial Profile
An Investigator Sponsored Phase I Trial of Selinexor Combined With Standard Capecitabine Based Chemoradiation as a Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2017
Price :
$35
*
At a glance
- Drugs Selinexor (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Adverse reactions
- 02 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 11 Jul 2014 New trial record